BRECISE is a five-year research project accelerating the clinical validation of AI-driven, NGS-based biomarkers in prostate and bladder cancer. It aims to support personalized treatment, improve patient outcomes, and enable integration into European healthcare systems.
This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No. 101194784. The JU receives support from the European Union’s Horizon Europe programme, COCIR, EFPIA, EuropaBio, MedTech Europe, and Vaccines Europe.
Company Details
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://brecise.eu/
- Keywords
- Cambridge.
Brecise Questions
Brecise's website is https://brecise.eu/
Brecise's LinkedIn profile is https://www.linkedin.com/company/brecise
Brecise's industry is
Biotechnology Research
Brecise's top competitors are
Sinisa,
Biomap Imi,
Ucec,
Pancaid,
Etransafe,
Genomate Health,
Fundación Oncosur,
Ohmx.bio,
Mwp4space,
Innovative Health Initiative (Ihi).
Brecise's categories are Biotechnology Research
